Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liquid Biopsy Differentiation of Pancreatic Cancer From Non-Cancerous Pancreatic Disease Using Dielectrophoresis-Recovered Nanoparticles Carrying Cell-Free DNA and Protein Biomarkers.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Peptide Amphiphiles Hitchhike on Endogenous Biomolecules for Enhanced Cancer Imaging and Therapy.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

RNA-induced Allosteric Coupling Drives Viral Capsid Assembly.

PRX life·2025
Same author

Peptide Amphiphiles Hitchhike on Endogenous Biomolecules for Enhanced Cancer Imaging and Therapy.

bioRxiv : the preprint server for biology·2025
Same author

Dynamic Allostery: Evolution's Double-Edged Sword in Protein Function and Disease.

Journal of molecular biology·2025
Same author

Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay.

Science translational medicine·2025

Related Experiment Video

Updated: Jul 8, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Applying artificial intelligence and computational modeling to nanomedicine.

Sean Hamilton1, Benjamin R Kingston1

  • 1Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, 2720 S. Moody Avenue, Portland, OR 97201, United States.

Current Opinion in Biotechnology
|December 13, 2023
PubMed
Summary

Computational modeling and artificial intelligence accelerate nanomedicine development by analyzing complex data. These approaches improve the design and selection of nanoparticle delivery systems for targeted therapies.

More Related Videos

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.1K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K

Related Experiment Videos

Last Updated: Jul 8, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K
Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.1K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K

Area of Science:

  • Nanomedicine
  • Computational Biology
  • Artificial Intelligence

Background:

  • Targeted delivery of nanomedicines to diseased tissues presents a significant challenge due to complex multivariate interactions in formulation and selection.
  • Current methods for developing nanoparticle delivery vehicles are time-consuming and involve extensive experimentation.

Purpose of the Study:

  • To explore the application of computational modeling and artificial intelligence (AI) in accelerating nanomedicine development.
  • To demonstrate how these computational approaches can optimize the design and selection of nanoparticle carriers for targeted drug delivery.

Main Methods:

  • Utilizing computational modeling for analyzing large, multivariate datasets inherent in nanomedicine research.
  • Applying AI techniques to interpret complex nanoparticle-biological interactions.
  • Developing predictive models from high-throughput screening data to identify optimal nanoparticle formulations.

Main Results:

  • Computational approaches significantly reduce the time and experimental effort required for nanomedicine development.
  • AI and modeling enable more efficient interpretation of nanoparticle-biological interactions.
  • Improved selection of ideal nanoparticle carriers is achievable through data-driven computational methods.

Conclusions:

  • Computational modeling and AI are powerful tools for overcoming challenges in targeted nanomedicine delivery.
  • Future nanomedicine development will increasingly rely on computational methods for faster and more efficient formulation selection.
  • Integrating AI into the nanomedicine pipeline promises to streamline the journey from concept to clinical application.